You searched for metabolic diseases - Page 57 of 64

News and Trends 7 Oct 2016

Meet the ‘Haut-Couturiers’ of Bioengineering

…and deletion of genes and the modification of metabolic pathways in bacterial strains and yeasts, enabling the development of efficient bioproduction systems. The great innovation of this site-specific technology is…

October 7, 2016 - 3 minutesmins - By Jerome Topsent

News and Trends 6 Dec 2022

Avalon BioVentures to invest in early-stage biotech

…50 biotech and health tech companies. Portfolio companies have advanced drug candidates across a broad range of disease indications including cancer, celiac disease, infectious disease, metabolic disease, neurodegeneration, and rare…

December 6, 2022 - 2 minutesmins - By Jim Cornall

tumor cancer immunotherapy alderaan biotech

News and Trends 17 Jun 2020

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

…in cancer as well as other diseases such as malaria and metabolic conditions. One of the most advanced oncology biotechs targeting this same protein is US-based Vigeo Therapeutics, whose lead…

June 17, 2020 - 2 minutesmins - By Victor Kotsev

News and Trends 26 Nov 2015

Ablynx Top Trumps: Adding Danish Diabetes Giant Novo Nordisk to its Biotech Deck

…new partnerships examples of lows…I can therefore only speculate this mysterious ‘disease area’ is likely in the metabolic and chronic field, such as diabetes. We shall see soon, I suppose….

November 26, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 1 Feb 2023

Advancing cancer care with 3D genomics

…types, including genomic, epigenomic, transcriptomic, proteomic, and metabolic profiles. It relies on the belief that subsequent machine learning data analyses will capture meaningful insights from this data, despite there often…

February 1, 2023 - 7 minutesmins - By External Contributor

In Depth 20 Mar 2024

Are molecular glues the key to undruggable targets?

…coined more than three decades ago, and its potential impact in treating diseases has been realized for a while now, however, developing them has proven to be quite challenging. This…

March 20, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 21 Apr 2017

The World’s Most Expensive Drugs have European Owners

A new report has listed the world’s most expensive drugs. Not surprisingly, those targeting rare diseases bear the heaviest price tags – let’s have a look. While biotechs like Généthon…

April 21, 2017 - 4 minutesmins - By Melanie De Almeida

News and Trends 8 Nov 2022

Rallybio announces positive phase 1 results for drug treating PNH and gMG

…diseases. Since its launch in January 2018, it has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areas of hematology,…

November 8, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 28 Aug 2024

GLP-1 shortage: Can biotech companies keep up with rising demand?

…added Patrik Jonsson, executive vice president, and president of Lilly Cardiometabolic Health and Lilly USA, in a press release. Moreover, Lilly’s main contender, the Danish multinational Novo Nordisk, is investing…

August 28, 2024 - 6 minutesmins - By Roohi Mariam Peter

News and Trends 25 Jul 2023

Roche and Alnylam to work on RNAi therapeutic to treat hypertension

…transform the landscape for patients with severe cardiovascular diseases,” said Yvonne Greenstreet, chief executive officer of Alnylam. “With this collaboration, we now can develop zilebesiran in a more robust way,…

July 25, 2023 - 5 minutesmins - By Jim Cornall

In Depth 23 May 2022

The coming of age of European synthetic biology

…human consumption. “Investors see the promise behind synbio being able to produce many molecules in a much more sustainable and efficient way. With synbio, any metabolic pathway is theoretically accessible…

May 23, 2022 - 8 minutesmins - By Helen Albert

News and Trends 23 Jan 2018

NASH Leader goes Pediatric with Clinical Trial Launch in US

The FDA has cleared Genfit to kick off clinical trials to see if its NASH drug, elafibranor, can also help children. Genfit develops diagnostic and therapeutic tools for metabolic and…

January 23, 2018 - 2 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Meet the ‘Haut-Couturiers’ of Bioengineering

Avalon BioVentures to invest in early-stage biotech

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

Ablynx Top Trumps: Adding Danish Diabetes Giant Novo Nordisk to its Biotech Deck

Advancing cancer care with 3D genomics

Are molecular glues the key to undruggable targets?

The World’s Most Expensive Drugs have European Owners

Rallybio announces positive phase 1 results for drug treating PNH and gMG

GLP-1 shortage: Can biotech companies keep up with rising demand?

Roche and Alnylam to work on RNAi therapeutic to treat hypertension

The coming of age of European synthetic biology

NASH Leader goes Pediatric with Clinical Trial Launch in US

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!